Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Galeotti

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 23, 2000
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activityD Manetti, C Ghelardini, A Bartolini, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptanC Ghelardini, N Galeotti, M Figini, et al.
Neuroreport|October 6, 1998
Kv1.1 channel antisense attenuates learning and modulation of dentate polysialylated NCAME Gratacós, C Ghelardini, L M Gherardini, et al.
Journal of Neurochemistry|March 21, 2002
Endogenous morphine modulates acute thermonociception in miceM Guarna, E Bianchi, A Bartolini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 6, 2003
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)N Galeotti, C Ghelardini, A Pittaluga, et al.
Neuropharmacology|January 29, 2026
The potent and selective adenosine A<sub>2A</sub>R antagonists P400 and P625 protect against symptoms in autoimmune experimental encephalomyelitis by attenuating neuroinflammation and demyelinationM Morozzi, V Borgonetti, C Sasia, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
Antinociceptive profile of 3-alpha-tropanyl 2-(4-Cl-phenoxy)butyrate (SM-21) [corrected]: a novel analgesic with a presynaptic cholinergic mechanism of actionC Ghelardini, N Galeotti, F Gualtieri, et al.
Journal of Medicinal Chemistry|May 23, 2000
Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agentsD Manetti, C Ghelardini, A Bartolini, et al.
Journal of Medicinal Chemistry|May 27, 1994
Presynaptic cholinergic modulators as potent cognition enhancers and analgesic drugs. 2. 2-Phenoxy-, 2-(phenylthio)-, and 2-(phenylamino)alkanoic acid estersF Gualtieri, C Bottalico, A Calandrella, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and ratN Meiri, C Ghelardini, G Tesco, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 23, 2000
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activityD Manetti, C Ghelardini, A Bartolini, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptanC Ghelardini, N Galeotti, M Figini, et al.
Neuroreport|October 6, 1998
Kv1.1 channel antisense attenuates learning and modulation of dentate polysialylated NCAME Gratacós, C Ghelardini, L M Gherardini, et al.
Journal of Neurochemistry|March 21, 2002
Endogenous morphine modulates acute thermonociception in miceM Guarna, E Bianchi, A Bartolini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 6, 2003
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)N Galeotti, C Ghelardini, A Pittaluga, et al.
Neuropharmacology|January 29, 2026
The potent and selective adenosine A<sub>2A</sub>R antagonists P400 and P625 protect against symptoms in autoimmune experimental encephalomyelitis by attenuating neuroinflammation and demyelinationM Morozzi, V Borgonetti, C Sasia, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
Antinociceptive profile of 3-alpha-tropanyl 2-(4-Cl-phenoxy)butyrate (SM-21) [corrected]: a novel analgesic with a presynaptic cholinergic mechanism of actionC Ghelardini, N Galeotti, F Gualtieri, et al.
Journal of Medicinal Chemistry|May 23, 2000
Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agentsD Manetti, C Ghelardini, A Bartolini, et al.
Journal of Medicinal Chemistry|May 27, 1994
Presynaptic cholinergic modulators as potent cognition enhancers and analgesic drugs. 2. 2-Phenoxy-, 2-(phenylthio)-, and 2-(phenylamino)alkanoic acid estersF Gualtieri, C Bottalico, A Calandrella, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and ratN Meiri, C Ghelardini, G Tesco, et al.
Pageof 8